{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:49:32Z","timestamp":1790808572079,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.iccl.2025.12.010","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:42:38Z","timestamp":1770241358000},"page":"307-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Next-Generation Drug Delivery Systems and Drugs for Vascular Intervention"],"prefix":"10.1016","volume":"15","author":[{"given":"Logan D.","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib1","first-page":"28","article-title":"Charles Theodore dotter. The father of intervention","volume":"28","author":"Payne","year":"2001","journal-title":"Tex Heart Inst J"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.010_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.12793\/tcp.2023.31.e18","article-title":"A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy","volume":"31","author":"Dinc","year":"2023","journal-title":"Transl Clin Pharmacol"},{"key":"10.1016\/j.iccl.2025.12.010_bib3","article-title":"Vascular smooth muscle cells in intimal hyperplasia, an update","volume":"13","author":"D\u00e9glise","year":"2022","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.010_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.addr.2006.01.014","article-title":"Drug-eluting stents: a multidisciplinary success story","volume":"58","author":"Burt","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"23","key":"10.1016\/j.iccl.2025.12.010_bib5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.iccl.2025.12.010_bib6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.010_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamacardio.2024.4244","article-title":"Drug-Coated balloons for the treatment of coronary artery disease: a review","volume":"10","author":"Camaj","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.010_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.2024.9523","article-title":"Coronary In-Stent restenosis treated with paclitaxel-coated balloon vs uncoated balloon-reply","volume":"332","author":"Yeh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.iccl.2025.12.010_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2016.08.018","article-title":"Materials technology in drug eluting balloons: current and future perspectives","volume":"239","author":"Xiong","year":"2016","journal-title":"J Control Release"},{"issue":"9591","key":"10.1016\/j.iccl.2025.12.010_bib11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.iccl.2025.12.010_bib12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/ATVBAHA.123.318450","article-title":"Less is more: developments in nanotechnology for antirestenosis therapies","volume":"43","author":"Trepanier","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"10.1016\/j.iccl.2025.12.010_bib13","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.010_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCINTERVENTIONS.111.963256","article-title":"Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials","volume":"4","author":"de Waha","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.iccl.2025.12.010_bib15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jcin.2013.07.009","volume":"6","author":"Gada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.iccl.2025.12.010_bib16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","volume":"8","author":"Smits","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.iccl.2025.12.010_bib17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jcin.2012.12.125","article-title":"Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents","volume":"6","author":"Kandzari","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.010_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcin.2012.12.123","article-title":"The \u201cfinal\u201d 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent","volume":"6","author":"Kirtane","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.010_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","volume":"6","author":"Serruys","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.iccl.2025.12.010_bib20","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.010_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4244\/EIJV6I2A32","article-title":"A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study","volume":"6","author":"Serruys","year":"2010","journal-title":"EuroIntervention"},{"issue":"7","key":"10.1016\/j.iccl.2025.12.010_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24317","article-title":"Real-World clinical performance of a Novolimus-Eluting stent versus a sirolimus-eluting stent","volume":"47","author":"Chang","year":"2024","journal-title":"Clin Cardiol"},{"issue":"11","key":"10.1016\/j.iccl.2025.12.010_bib23","doi-asserted-by":"crossref","first-page":"e1336","DOI":"10.4244\/EIJY15M10_04","article-title":"DESyne novolimus-eluting coronary stent is superior to endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial","volume":"12","author":"Iqbal","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2025.12.010_bib24","article-title":"DESyne BDS plus study: a randomized clinical tiral of a novel triple drug (TRx) eluting coronary stent eluting two anticoagulants and sirolimus six-month clinical and imaging results","author":"Verheye","year":"2023","journal-title":"Transcatheter Cardiovascular Therapeutics (TCT)"},{"issue":"5","key":"10.1016\/j.iccl.2025.12.010_bib25","article-title":"CD34-Structure, functions and relationship with cancer stem cells","volume":"59","author":"Radu","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.010_bib26","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIRCRESAHA.121.319494","article-title":"Nonbone marrow CD34(+) cells are crucial for endothelial repair of injured artery","volume":"129","author":"Jiang","year":"2021","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.010_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2217\/fca-2018-0051","article-title":"The dual-therapy COMBO stent: a rationale for a light dual antiplatelet therapy treatment","volume":"14","author":"Baldetti","year":"2018","journal-title":"Future Cardiol"},{"issue":"22","key":"10.1016\/j.iccl.2025.12.010_bib28","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1161\/CIRCULATIONAHA.120.052766","article-title":"Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting combo stent with the sirolimus-eluting orsiro stent in patients treated with percutaneous coronary intervention: the SORT OUT X trial","volume":"143","author":"Jakobsen","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.iccl.2025.12.010_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.carrev.2019.04.016","article-title":"Clinical outcomes of the dual-therapy CD34 antibody-covered sirolimus-eluting stent versus standard drug-eluting coronary stents: a meta-analysis","volume":"21","author":"Ndunda","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"issue":"18","key":"10.1016\/j.iccl.2025.12.010_bib30","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/eurheartj\/ehab027","article-title":"Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo","volume":"42","author":"Diaz-Rodriguez","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.iccl.2025.12.010_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/CIRCRESAHA.120.315935","article-title":"CD31 as a therapeutic target in atherosclerosis","volume":"126","author":"Caligiuri","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.iccl.2025.12.010_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yjmcc.2018.07.007","article-title":"Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits","volume":"121","author":"Hyt\u00f6nen","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.010_bib33","first-page":"3482","article-title":"A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice","volume":"8","author":"Xu","year":"2016","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3892\/mmr.2016.5986","article-title":"A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model","volume":"15","author":"Huang","year":"2017","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cardiores.2004.06.013","article-title":"Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries","volume":"64","author":"Banai","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.010_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/01.fjc.0000246940.91191.1f","article-title":"Stent-based delivery of antisense oligodeoxynucleotides targeted to the PDGF A-chain decreases in-stent restenosis of the coronary artery","volume":"48","author":"Li","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.010_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/14628840310017177","article-title":"Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placement","volume":"5","author":"Serruys","year":"2003","journal-title":"Int J Cardiovasc Intervent"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.010_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.010_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.ATV.0000157582.33180.a9","article-title":"Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries","volume":"25","author":"Johnson","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.iccl.2025.12.010_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.760140","article-title":"Gene therapy for cardiovascular disease: basic research and clinical prospects","volume":"8","author":"Cao","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110196","article-title":"Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA","volume":"38","author":"Zhang","year":"2022","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.010_bib42","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1166\/jbn.2016.2255","article-title":"Therapeutic effect of Akt1 siRNA nanoparticle eluting coronary stent on suppression of post-angioplasty restenosis","volume":"12","author":"Che","year":"2016","journal-title":"J Biomed Nanotechnol"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.010_bib43","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1161\/ATVBAHA.118.312212","article-title":"PI3K\u03b3 (phosphoinositide 3-Kinase \u03b3) regulates vascular smooth muscle cell phenotypic modulation and neointimal Formation through CREB (Cyclic AMP-Response element binding Protein)\/YAP (Yes-Associated protein) signaling","volume":"39","author":"Yu","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.010_bib44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/CIRCINTERVENTIONS.114.001522","article-title":"Prevention of neointimal formation after angioplasty using nuclear factor-\u03baB decoy oligodeoxynucleotide-coated balloon catheter in rabbit model","volume":"7","author":"Miyake","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.iccl.2025.12.010_bib45","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.ebiom.2015.09.045","article-title":"BET Bromodomain blockade mitigates intimal hyperplasia in rat carotid arteries","volume":"2","author":"Wang","year":"2015","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.iccl.2025.12.010_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11050210","article-title":"Nanomedicines for the delivery of biologics","volume":"11","author":"Wahlich","year":"2019","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.iccl.2025.12.010_bib47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1540-8183.2006.00198.x","article-title":"Polymers, drug release, and drug-eluting stents","volume":"19","author":"Commandeur","year":"2006","journal-title":"J Interv Cardiol"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.010_bib48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.118.038065","article-title":"Ten-Year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease","volume":"139","author":"Kufner","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.010_bib49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14797\/mdcj-12-3-163","article-title":"Enhancing stent effectiveness with nanofeatures","volume":"12","author":"Bassous","year":"2016","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12872-021-02356-0","article-title":"Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry","volume":"21","author":"Dai","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.iccl.2025.12.010_bib51","article-title":"Advances in the development of biodegradable coronary stents: a translational perspective","volume":"16","author":"Zong","year":"2022","journal-title":"Mater Today Bio"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.010_bib52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.010_bib53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.010_bib54","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCRESAHA.117.310275","article-title":"Bioresorbable scaffold: the emerging reality and future directions","volume":"120","author":"Sotomi","year":"2017","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13063-022-07028-8","article-title":"The standard versus prolonged dual antiplatelet therapy after the XINSORB bioresorbable scaffold implantation (SPARTA) trial: study protocol for a randomized controlled trial","volume":"24","author":"Wu","year":"2023","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jbm.b.30518","article-title":"Collapse pressures of bilayered biodegradable stents","volume":"79","author":"Tan","year":"2006","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.iccl.2025.12.010_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2022.100922","article-title":"Current status and future direction of metallic and polymeric materials for advanced vascular stents","volume":"126","author":"Im","year":"2022","journal-title":"Prog Mater Sci"},{"issue":"10059","key":"10.1016\/j.iccl.2025.12.010_bib58","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.iccl.2025.12.010_bib59","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jcin.2017.09.041","article-title":"The state of the absorb bioresorbable scaffold: consensus from an expert panel","volume":"10","author":"Bangalore","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"10.1016\/j.iccl.2025.12.010_bib60","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.010_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jacc.2023.05.003","article-title":"5-Year outcomes after bioresorbable coronary scaffolds implanted with improved technique","volume":"82","author":"Stone","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"10464","key":"10.1016\/j.iccl.2025.12.010_bib62","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(24)02227-X","article-title":"Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial","volume":"404","author":"Erlinge","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.iccl.2025.12.010_bib63","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jcin.2016.02.051","article-title":"Bioresorbable everolimus-eluting vascular scaffold for patients with peripheral artery disease (ESPRIT I): 2-Year clinical and imaging results","volume":"9","author":"Lammer","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.010_bib64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcin.2013.09.009","article-title":"Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study","volume":"7","author":"Werner","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.iccl.2025.12.010_bib65","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jvs.2016.05.066","article-title":"Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent","volume":"64","author":"Bontinck","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.iccl.2025.12.010_bib66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jvssci.2022.03.002","article-title":"Intravascular treatment of long segments of experimental peripheral arteries with multiple, serial, balloon-expandable, resorbable scaffolds","volume":"3","author":"El Khoury","year":"2022","journal-title":"JVS Vasc Sci"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib67","first-page":"150","article-title":"Everolimus eluting bioresorbable vascular scaffolds for infrapopliteal critical limb ischemia: moving beyond grasping at metal straws","volume":"97","author":"Winscott","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2025.12.010_bib68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.31083\/j.rcm2504133","article-title":"Bioresorbable scaffolds for below-the-knee arterial disease: a literature review of new developments","volume":"25","author":"Cui","year":"2024","journal-title":"Rev Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.iccl.2025.12.010_bib69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00270-008-9472-8","article-title":"AMS INSIGHT--absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis","volume":"32","author":"Bosiers","year":"2009","journal-title":"Cardiovasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.iccl.2025.12.010_bib70","first-page":"E1","article-title":"BIOSOLVE-IV-registry: safety and performance of the magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients","volume":"98","author":"Verheye","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.iccl.2025.12.010_bib71","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.119.043467","article-title":"Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-Segment elevation myocardial infarction: the MAGSTEMI randomized clinical trial","volume":"140","author":"Sabat\u00e9","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2025.12.010_bib72","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.actbio.2020.01.028","article-title":"Towards revealing key factors in mechanical instability of bioabsorbable Zn-based alloys for intended vascular stenting","volume":"105","author":"Mostaed","year":"2020","journal-title":"Acta Biomater"},{"issue":"8","key":"10.1016\/j.iccl.2025.12.010_bib73","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jcin.2025.01.426","article-title":"Percutaneous coronary treatment with bioadaptor implant vs drug-eluting stent: 2-Year outcomes from BIOADAPTOR RCT","volume":"18","author":"Saito","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"10.1016\/j.iccl.2025.12.010_bib74","article-title":"The future of cardiovascular stents: bioresorbable and integrated biosensor technology","volume":"6","author":"Hoare","year":"2019","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"10.1016\/j.iccl.2025.12.010_bib75","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1021\/acs.biomac.0c01082","article-title":"Advancing toward 3D printing of bioresorbable shape memory polymer stents","volume":"21","author":"Yeazel","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.iccl.2025.12.010_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121153","article-title":"3D printing advances in the development of stents","volume":"609","author":"Khalaj","year":"2021","journal-title":"Int J Pharm"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745825001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745825001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:55:40Z","timestamp":1773672940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745825001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2211745825001117"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2025.12.010","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-Generation Drug Delivery Systems and Drugs for Vascular Intervention","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2025.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}